Who
Richard Alistair Stewart
Director
Company insider
Files Form 4 as: Chief Executive Officer, Achieve Life Sciences.
In numbers
- Trades disclosed
- 51
- Buys
- 3
- Sells
- 2
- Bought
- $138K
- Sold
- $728K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Aug 2017
- Last trade
- 19 Aug 2026
- Last filed
- 21 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 21 Aug 2026 | ACHV Achieve Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $175K20,626 at $8.49 | filing |
| 19 Aug 2026filed 21 Aug 2026 | ACHV Achieve Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $175K20,626 at $8.49 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,700 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,700 at $0.00 | filing |
| 28 Jan 2026filed 30 Jan 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —645,000 at $0.00 | filing |
| 28 Jan 2026filed 30 Jan 2026 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —645,000 at $0.00 | filing |
| 18 Sep 2025filed 22 Sep 2025 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —140,000 at $0.00 | filing |
| 18 Sep 2025filed 22 Sep 2025 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —157,500 at $0.00 | filing |
| 18 Sep 2025filed 22 Sep 2025 | ACHV Achieve Life SciencesDiagnostics & Labs | SEC FORM 4 Code M | —297,500 at $0.00 | filing |
| 18 Sep 2025filed 22 Sep 2025 | ACHV Achieve Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $378K129,501 at $2.92 | filing |
| 4 Sep 2025filed 8 Sep 2025 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 4 Sep 2025filed 8 Sep 2025 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —157,500 at $0.00 | filing |
| 17 Mar 2025filed 19 Mar 2025 | ACHV Achieve Life SciencesDiagnostics & Labs | SEC FORM 4 Bought | $29K10,000 at $2.86 | filing |
| 13 Jan 2025filed 14 Jan 2025 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —157,500 at $0.00 | filing |
| 13 Jan 2025filed 14 Jan 2025 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —67,500 at $0.00 | filing |
| 19 Apr 2024filed 23 Apr 2024 | ACHV Achieve Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —22,500 at $0.00 | filing |
| 19 Apr 2024filed 23 Apr 2024 | ACHV Achieve Life SciencesDiagnostics & Labs | SEC FORM 4 Code M | —22,500 at $0.00 | filing |
| 19 Apr 2024filed 23 Apr 2024 | ACHV Achieve Life SciencesDiagnostics & Labs | SEC FORM 4 Code F | $46K10,125 at $4.51 | filing |
News
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026ACHV · manilatimes.net · 21 Oct 2026
0 headlines in the last 90 days name Richard Alistair Stewart; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.